No Picture

Osiris FDA Letter: Trick or Treat?

October 29, 2013 Paul Knoepfler 3

Osiris, a cellular therapy biotech, recently received a so-called “untitled letter” from the FDA. The text of the letter seems on the whole negative in my opinion, while the company’s public reaction to the letter on the other hand could […]